These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 15655620)
21. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors. Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138 [TBL] [Abstract][Full Text] [Related]
22. The role of primary care in colorectal cancer screening: experience from Czech Republic. Seifert B; Zavoral M; Fric P; Bencko V Neoplasma; 2008; 55(1):74-80. PubMed ID: 18190246 [TBL] [Abstract][Full Text] [Related]
23. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening. Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600 [TBL] [Abstract][Full Text] [Related]
24. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan. Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635 [TBL] [Abstract][Full Text] [Related]
25. Is it reasonable to use faecal occult blood test for colorectal cancer screening? Musil D; Tillich J Acta Univ Palacki Olomuc Fac Med; 1999; 142():119-21. PubMed ID: 10743740 [TBL] [Abstract][Full Text] [Related]
26. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M; J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571 [TBL] [Abstract][Full Text] [Related]
27. Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence. Grazzini G; Ciatto S; Cislaghi C; Castiglione G; Falcone M; Mantellini P; Zappa M; J Med Screen; 2008; 15(4):175-81. PubMed ID: 19106257 [TBL] [Abstract][Full Text] [Related]
28. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Kronborg O; Jørgensen OD; Fenger C; Rasmussen M Scand J Gastroenterol; 2004 Sep; 39(9):846-51. PubMed ID: 15513382 [TBL] [Abstract][Full Text] [Related]
29. [Screening of the sporadic colorectal cancer]. Zavoral M; Závada F Cas Lek Cesk; 2007; 146(12):950-4. PubMed ID: 18257413 [TBL] [Abstract][Full Text] [Related]
30. Colorectal cancer test use from the 2005 National Health Interview Survey. Shapiro JA; Seeff LC; Thompson TD; Nadel MR; Klabunde CN; Vernon SW Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1623-30. PubMed ID: 18628413 [TBL] [Abstract][Full Text] [Related]
31. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589 [TBL] [Abstract][Full Text] [Related]
32. Increase in screening for colorectal cancer in older Americans: results from a national survey. Chen X; White MC; Peipins LA; Seeff LC J Am Geriatr Soc; 2008 Aug; 56(8):1511-6. PubMed ID: 18662217 [TBL] [Abstract][Full Text] [Related]
33. The feasibility of FOBT tests in colorectal cancer screening in Dobrogea. Suceveanu AI; Suceveanu A; Dumitru E; Alexandrescu L; Voinea F Rom J Gastroenterol; 2005 Sep; 14(3):213-7. PubMed ID: 16200229 [TBL] [Abstract][Full Text] [Related]
34. Quantitative colonoscopic evaluation of relative efficiencies of an immunochemical faecal occult blood test and a sensitive guaiac test for detecting significant colorectal neoplasms. Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Niv Y Aliment Pharmacol Ther; 2009 Feb; 29(4):450-7. PubMed ID: 19035980 [TBL] [Abstract][Full Text] [Related]
35. Colorectal cancer test use--Maryland, 2002-2006. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446 [TBL] [Abstract][Full Text] [Related]
36. [Screening for colorectal cancer with an immunological fecal occult blood test]. Fernández JL; Gallegos M; Brochero A; Arévalo C; Piccioni H; Gutiérrez Galiana H Acta Gastroenterol Latinoam; 1999; 29(2):73-8. PubMed ID: 10491719 [TBL] [Abstract][Full Text] [Related]
37. Utilization of lower gastrointestinal endoscopy and fecal occult blood test in 11 European countries: evidence from the Survey of Health, Aging and Retirement in Europe (SHARE). Stock C; Brenner H Endoscopy; 2010 Jul; 42(7):546-56. PubMed ID: 20432204 [TBL] [Abstract][Full Text] [Related]
38. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Shiratori Y Gastroenterology; 2005 Aug; 129(2):422-8. PubMed ID: 16083699 [TBL] [Abstract][Full Text] [Related]
39. Colorectal carcinoma screening procedure use among primary care patients. Lafata JE; Williams LK; Ben-Menachem T; Moon C; Divine G Cancer; 2005 Oct; 104(7):1356-61. PubMed ID: 16092119 [TBL] [Abstract][Full Text] [Related]
40. [Knowledge of colorectal cancer prevention in the Bavarian population above 50 years--survey in two districts]. Loss J; Eichhorn C; Nagel E Gesundheitswesen; 2005 Jul; 67(7):455-60. PubMed ID: 16103968 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]